Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 17.60
-0.50 (-2.76%)
At close: Aug 26, 2026
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €3.44 billion as of August 26, 2026. Its market cap has decreased by -37.08% in one year.
Market Cap
3.44B
Enterprise Value
2.85B
Revenue
1.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.60
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 3.44B, a decrease of -18.67%. That is a compound annual growth rate of -3.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 3.44B | 0.57% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 23.64M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 225.65K |